Asensus Surgical Inc.

3.20-0.1500-4.48%Vol 18.15M1Y Perf 392.05%
Jun 18th, 2021 16:00 DELAYED
BID3.20 ASK3.25
Open3.33 Previous Close3.35
Pre-Market- After-Market-
 - -  - -%
Target Price
4.00 
Analyst Rating
— — 0.00
Potential %
25.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.87
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.38
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap746.20M 
Earnings Rating
Price Range Ratio 52W %
43.61 
Earnings Date
4th Aug 2021

Today's Price Range

3.063.42

52W Range

0.30006.95

5 Year PE Ratio Range

-1.70-0.3000

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-0.62%
1 Month
60.80%
3 Months
-22.89%
6 Months
479.71%
1 Year
392.05%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ASXC3.20-0.1500-4.48
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Financial StrengthValueIndustryS&P 500US Markets
17.60
19.20
0.02
0.03
-2 341.70
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-40.40
-1 307.10
-1 001.50
-2 875.00
-
RevenueValueIndustryS&P 500US Markets
4.66M
0.02
-35.86
-
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.07-0.0614.29
Q04 2020--0.09-
Q03 2020-0.23-0.1247.83
Q02 2020-0.38-0.2144.74
Q01 2020-0.53-0.4122.64
Q04 2019--0.83-
Q03 2019-0.91-1.17-28.57
Q02 2019-1.04-1.17-12.50
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2021
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume18.15M
Shares Outstanding233.19M
Trades Count30.30K
Dollar Volume0
Avg. Volume23.61M
Avg. Weekly Volume9.02M
Avg. Monthly Volume14.83M
Avg. Quarterly Volume11.78M

Asensus Surgical Inc. (AMEX: ASXC) stock closed at 3.2 per share at the end of the most recent trading day (a -4.48% change compared to the prior day closing price) with a volume of 18.54M shares and market capitalization of 746.20M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 138 people. Asensus Surgical Inc. CEO is Anthony C. J. Fernando.

The one-year performance of Asensus Surgical Inc. stock is 392.05%, while year-to-date (YTD) performance is 412%. ASXC stock has a five-year performance of %. Its 52-week range is between 0.3 and 6.95, which gives ASXC stock a 52-week price range ratio of 43.61%

Asensus Surgical Inc. currently has a PE ratio of -5.60, a price-to-book (PB) ratio of 3.65, a price-to-sale (PS) ratio of 171.70, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -38.54%, a ROC of -42.46% and a ROE of -43.53%. The company’s profit margin is -%, its EBITDA margin is -1 001.50%, and its revenue ttm is $4.66 Million , which makes it $0.02 revenue per share.

Of the last four earnings reports from Asensus Surgical Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Asensus Surgical Inc.’s next earnings report date is 04th Aug 2021.

The consensus rating of Wall Street analysts for Asensus Surgical Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Asensus Surgical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Asensus Surgical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Asensus Surgical Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 71.30, ATR14 : 0.32, CCI20 : 51.34, Chaikin Money Flow : 0.01, MACD : 0.30, Money Flow Index : 73.84, ROC : 29.03, RSI : 57.27, STOCH (14,3) : 61.81, STOCH RSI : 0.00, UO : 54.72, Williams %R : -38.19), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Asensus Surgical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Asensus Surgical Inc.

Asensus Surgical Inc is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

CEO: Anthony C. J. Fernando

Telephone: +1 919 765-8400

Address: 1 TW Alexander Drive, Durham 27703, NC, US

Number of employees: 138

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

80%20%

Bearish Bullish

70%30%

Bearish Bullish

89%11%

News

Stocktwits